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Abstract 
We investigated the clinical and cost-effectiveness of using a locking versus non-locking 
fixation plate in medial opening wedge high tibial osteotomy (HTO) for patients with medial 
compartment knee osteoarthritis. Medical charts were retrospectively reviewed up to 12 
months following HTO for 144 patients who received a locking plate and 105 patients who 
received a non-locking plate. Surgeon notes provided the time to return to full weight-
bearing. Participants had completed the Knee injury and Osteoarthritis Outcome Score 
(KOOS) preoperatively, six and 12 months postoperatively. Hospital and provincial 
administrative databases provided direct and indirect cost data. Improvements in KOOS 
scores were similar between groups. The locking plate was more expensive and therefore its 
use was not cost-effective from the healthcare payer perspective. However, the locking plate 
enabled statistically shorter time to return to full weight-bearing, translating to a faster return 
to work, and therefore its use was cost-effective from the societal perspective.  
 
Keywords 
Key terms: knee; osteoarthritis; high tibial osteotomy; locking plate; ContourLock; weight-
bearing; patient reported outcomes; KOOS; cost-effectiveness; economic analysis 
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Chapter 1  
1 Introduction 
1.1 Background & Rationale 
Osteoarthritis (OA) is a common degenerative health condition and a leading cause of 
pain, disability and reduced quality of life in adult populations worldwide1. As a chronic 
condition, the symptoms of the disease can persist for decades, resulting in substantial 
economic burden to healthcare systems. In Canada, arthritis accounted for $6.4 billion of 
direct and indirect healthcare costs in the year 2000, OA being responsible for the 
majority of these costs2. These costs are expected to continue to grow with the aging 
population and the rising rate of obesity3. Therefore, the identification of cost-effective 
treatments for OA is of utmost concern for public health strategists2.  
Osteoarthritis commonly involves the knee, with an estimated 250 million people 
currently affected globally4. Although there is no known cure for knee OA, there are 
several identified risk factors for knee OA progression that form the targets of various 
interventions5–8. Varus alignment of the lower limb is a particularly strong risk factor for 
the progression of knee OA due to its effect on loading the medial tibiofemoral 
compartment9–13. Surgical and non-surgical treatments aimed at altering loads on the 
medial tibiofemoral compartment are therefore common14–17. 
Medial opening wedge high tibial osteotomy (HTO) is a surgical realignment procedure 
for patients with varus malalignment and OA of the medial compartment of the 
tibiofemoral joint15,18,19. The goals of HTO are to correct lower limb malalignment, 
redistribute loads laterally across the knee to lessen the compressive force on the diseased 
medial compartment, and thereby improve pain and function. The medial opening wedge 
technique requires cutting into the medial proximal tibia, wedging the bone open to a 
predetermined correction size to correct the malalignment, and securing the osteotomy 
with a fixation device18,20,21.  
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Adequate fixation of the osteotomy, typically achieved using an internal fixation plate, is 
vital for bone healing and  recovery during rehabilitation22,23,  that involves progressive  
weight-bearing using ambulatory aids (i.e. crutches, canes, etc.). The patient’s weight-
bearing status is progressed based on postoperative assessments of radiographic bone 
healing and pain. The suggested duration of return to full weight-bearing after medial 
opening wedge HTO ranges from 2 to 12 weeks, and highly depends on the type of 
fixation used24–30. 
HTO fixation plates are similar to those used for fracture fixation and can generally be 
categorized as non-locking and locking. The mechanical principles are quite different for 
non-locking and locking plates, providing distinct mechanical environments for bone 
healing. Non-locking plates rely on bone-plate compression and high friction at the bone-
plate interface to provide fracture site stability31. At higher loads, however, non-locking 
screws that are drilled into the bone can begin to loosen. This reduces bone-plate friction, 
may render the plate unstable and increases the risk of complications such as hardware 
failure, delayed union, non-union and loss of correction32. Locking plate designs address 
mechanical issues with threaded fixed-angle screws or interference washers that control 
the axial rotation between the screw and the plate, and eliminate screw-plate-bone 
motion33. The mechanism does not rely on high friction at the bone-plate interface, but 
rather maintains stability at the angular-stable screw-plate interface31. Locking plates also 
convert shear stresses to compressive stresses, improving fixation since bone has a 
stronger resistance to compressive stress compared to shear. The mechanical advantages 
of locking plates provide stronger implant stability and resistance to higher load-bearing, 
and are therefore suggested to be advantageous for healing after medial opening wedge 
HTO23,34.  
In vitro biomechanical studies have suggest that locking plates do provide greater 
mechanical stability in response to compression and torsion35,36. Clinical studies suggest 
locking plates maintain the osteotomy correction size better than non-locking plates37,38, 
provide faster improvements in patient-important outcomes37,38, enable faster time to 
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achieve bone healing37 and earlier return to full weight-bearing after surgery37,39,40. 
Although results are mixed, some studies also suggest that the rates of delayed and non-
union22,38, loss of correction and hardware failure have decreased since the introduction 
of locking plates 41.  
The Arthrex ContourLock HTO Plate® (ContourLock) is a relatively new locking plate 
designed to enable a precise fit proximally and distally on the tibia. The locking plate is 
proposed to provide advantages when compared to the commonly used non-locking 
Arthrex Puddu Plate® (Puddu). In-vitro biomechanical studies suggest the locking plate 
provides greater stability under high physiological stress loading and cyclical testing 
when compared to other locking and non-locking plates due to the wider distance 
between its fixed-angle screws42,43. Although the greater stability is proposed to permit 
faster recovery after surgery, there is currently no study evaluating clinical outcomes 
after HTO using the plate.  
The cost associated with using different HTO fixation plates is another important 
consideration. Costs of HTO include direct (healthcare resources consumed and out-of-
pocket expenses) and indirect (time and productivity losses) costs. If locking plates can 
limit the number of postoperative complications that require revision surgery (i.e. non-
union), locking plates could provide direct cost savings. Additionally, if locking plates 
enable quicker return to weight-bearing, patients could also return to work sooner, thus 
financially benefiting society with indirect cost savings from productivity. Alternatively, 
the cost of locking plates are substantially greater than non-locking plates because of 
their more complex design and number of screws (typically six or more, compared to 
four) used to achieve fixation. If clinical results are similar regardless of plate design then 
the extra costs of locking plates may not be warranted. Furthermore, the relative 
bulkiness of locking plates may cause irritation to the patients and require the plate to be 
surgically removed40,44 which can increase direct costs associated with the procedure. 
Importantly, the cost-effectiveness of different HTO fixation plate designs is currently 
unknown and requires research. Therefore the purpose of the present study is to compare 
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the clinical and cost-effectiveness of a locking plate (i.e., Arthrex ContourLock HTO 
Plate®) versus a non-locking plate (i.e., Arthrex Puddu Plate®) used for medial opening 
wedge HTO. Specific objective and hypotheses are listed below. 
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1.2 Study Objectives and Hypotheses 
1. To compare the time to return to full weight-bearing following medial opening 
wedge HTO in patients receiving a locking versus non-locking fixation plate. 
Hypothesis: Patients receiving the locking plate will return to full weight-bearing 
sooner postoperatively. 
 
2. To compare the change in patient-reported outcomes (Knee injury and 
Osteoarthritis Outcome Score – KOOS) following a medial opening wedge HTO 
in patients receiving a locking versus non-locking fixation plate. 
Hypothesis: Patients receiving the locking plate will experience greater 
improvements in patient-reported outcomes from baseline to 6 months after the 
surgery. 
 
3. To estimate the cost-effectiveness of a locking plate compared to a non-locking 
plate, from the healthcare payer (Ministry of Health) and societal perspectives, 
using change in KOOS total score at 12 months postoperative as the measure of 
effectiveness. 
Hypothesis: The locking plate will be cost-effective compared to the non-locking 
plate from both the healthcare payer and societal perspectives. 
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1.3 Review of Literature 
1.3.1 Osteoarthritis 
Osteoarthritis (OA) is the most common form of arthritis and is rapidly becoming one of 
the most disabling health conditions worldwide4,45–47. It is a chronic musculoskeletal 
disease that can affect single or multiple joints, and is characterized by localized joint 
pain, functional limitations and diminished quality of life1,48. In Canada, there are more 
than 4.4 million people (1 in 8) living with OA and this number is projected to double by 
the year of 2040 due to the aging population and the obesity epidemic49.       
 
1.3.1.1 Epidemiology 
According to the 2013 Global Burden of Disease (GBD) study, the prevalence of OA has 
grown 72% from the year 1990 with approximately 240 million people burdened by the 
disease worldwide 4. The chronic nature of OA also makes it one of the fastest growing 
health conditions in terms of disability46. It accounted for more than 17 million years 
living with disability (YLDs) globally in 2010, a 64% increase from the year of 199050. 
The World Health Organization (WHO) projects OA to become the fourth leading cause 
of disability worldwide by the year 202051.  
The disease is not isolated to a specific population group, but affects people of various 
ethnic backgrounds and in different geographical locations worldwide52. Although OA 
can be seen in people as young as 15 years of age, the majority of people affected by the 
disease are older individuals3,53 with women being affected approximately twice as often 
as men48. 
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1.3.2 Knee Osteoarthritis 
OA develops more frequently in the knee than any other weight-bearing joint in the 
body54–56 with over 10% of the adult population currently affected by symptomatic knee 
OA49. Due to the high loading demands on the joint, knee OA specifically is considered 
one of the leading causes of physical disability worldwide57,58. The lifetime risk of 
developing knee OA is estimated to be 45% (47% in women, 40% in men) with increased 
odds seen in those who possess predisposing risk factors for the disease such as obesity 
and malalignment, among others59.  
 
1.3.2.1 Knee Anatomy 
The knee is a complex synovial hinge joint between the patella, the distal femur and the 
proximal tibia60. The bone surfaces are lined with hyaline (articular) cartilage which aids 
in dissipating forces within the joint and limiting friction between bones. The cartilage 
tissue is not innervated by pain receptors, nor is it well vascularized which limits the 
tissue’s ability to repair itself61. Aside from the surfaces concealed by articular cartilage, 
the inner lining of the joint is covered by a layer of connective tissue called the synovial 
membrane, or synovium. Its cells secrete synovial fluid, a viscous substance which 
reduces the level of friction within the joint space and provides nutrients to surrounding 
tissues whose supply of blood is poor, such as the menisci. There is a meniscus for each 
knee compartment (medial and lateral) between the articulating surfaces of the femur and 
the tibia. Their function is to assist with force dissipation from within the joint, improve 
knee joint stability and help lubricate the knee joint. Knee support is also maintained by 
various muscles and ligaments. The surrounding networks of muscle are important for 
assisting with shock absorption and initiation of movement about the knee. Ligaments are 
arranged in a manner that provides stability mediolaterally (collateral ligaments) and 
anteroposteriorly (cruciate ligaments) to the knee joint. 
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1.3.2.2 Pathophysiology 
Knee OA is a degenerative condition that affects the various tissues of the joint and is 
considered a whole-joint disease62. It is characterized by the disruption of the natural 
cartilage remodeling process, ultimately leading to the fibrillation and softening of the 
articular cartilage and intensified degeneration of the tissue63. As cartilage continues to 
breakdown, subchondral bone becomes exposed within the joint resulting in bone-on-
bone articulation. Continuous friction between exposed bone leads to the development of 
osteophytes and subchondral cysts at the articulating bone extremities due to excessive 
bone remodeling48,64. In later stages of the disease, the subchondral bone tissue will begin 
to thicken and become sclerotic. Additionally, it is common to see inflammation of the 
synovial lining of the joint46 as well of the overproduction of several proteolytic enzymes 
and cytokines that have been shown to promote cartilage degradation and breakdown of 
the extracellular matrix of the joint. These intra-articular changes and inflammatory 
responses ultimately lead to loss of joint space, destabilization of the joint, abnormal joint 
loading and a number of clinical symptoms for the affected individual. 
 
1.3.2.3 Etiology 
Similar to OA in other joints of the body, knee OA is a complex condition. The initial 
onset of the disease can be idiopathic in nature, developing naturally over time as a result 
of various interacting risk factors (known as primary OA), or can develop following 
excessive or repetitive trauma to the knee joint such as ligament tears, cartilage impact, 
etc. (known as secondary OA)47. There are still quite a few uncertainties that surround the 
etiology of the disease. Knee OA is unpredictable in its method of initiation and its 
progression, with some individuals exhibiting mild degeneration of the joint sustained 
over an extended period of time, while others progress in disease severity very rapidly. 
The medial compartment is the most commonly affected area of the joint when compared 
to other compartments of the knee8,65–67. The disease does not affect the entire joint 
uniformly.  
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1.3.2.4 Risk Factors for Knee OA 
As a disease whose onset and progression is quite variable, it is important to better 
understand the multiple risk factors that predispose individuals to developing knee OA 
and accelerate the progression of the disease. These risk factors can act systemically or 
can be considered local by acting directly on the joint itself (Figure 1).  
Systemic risk factors have a biochemical influence on the knee joint. These factors can 
cause direct damage to the joint tissues or limit the tissue’s ability to repair itself after 
being damaged, both of which make the affected individual susceptible to further injury. 
Systemic risk factors that have been associated with development of knee OA and its 
progression include age46,47, genetics46,47,62, gender6,46,62,68, overweight/obesity (BMI ≥ 
25)69,70, nutritional deficiencies71,72, inactivity72,73 and elevated bone mineral density74,75.  
Local risk factors influence the joint mechanically. These factors are associated with 
exposure to joint injury or excessive joint loading that leads to degeneration of tissues. 
Local risk factors that have been associated with development of knee OA and its 
progression include knee malalignment10,55,76,77, congenital deformities of the joint78, 
previous injuries to the tissue components of the joint6,62,79,80, overweight/obesity (BMI ≥ 
25)81–83, occupation62,79,84, muscle weakness85,86, elevated peak knee adduction moment9–
11,87,88, elevated knee adduction impulse89, and varus thrust90. 
Although risk factors have been shown to independently promote knee OA disease 
progression, the risks are intensified as individuals are exposed to multiple risk factors 
simultaneously. For example, mechanical varus alignment of the lower limb has been 
shown to increase the risk of medial compartment OA progression by a fourfold10,76 as a 
result of increased mechanical axial loading on the joint past a normal physiological 
range to maintain proper cartilage function. In overweight and obese individuals, the 
sheer excess weight increases this level of mechanical loading of the medial compartment 
leading to further articular cartilage breakdown. Various studies have suggested there is 
an interaction between lower limb alignment and obesity5,7. Moreover, associated 
10 
 
 
 
symptoms of pain resulting from knee OA can promote immobility and sedentary 
lifestyles, risk factors for obesity, which can lead to further progression of OA as the 
individual’s weight increases. For this reason, it is in the individual’s best interest to 
tackle as many potential risk factors that are modifiable to minimize the risk of 
developing knee OA or slow down disease progression. 
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Figure 1: Schematic representation of the interacting systemic (biochemical) and 
local (biomechanical) risk factors that are associated with the development of knee 
OA and progression of the disease. Also presented are the radiographic and clinical 
criteria used to diagnose knee OA according to Kellgren and Lawrence, 1957 and 
Altman et al., 1986. 
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1.3.2.4.1 Varus Alignment 
Lower limb alignment is typically determined using full-limb standing hip-knee-ankle 
(HKA) anteroposterior (AP) radiographs. The gold standard measure of lower limb 
alignment is the mechanical axis angle (MAA), defined as the angle formed between the 
line connecting the femoral head center of the hip and the knee joint center and the line 
connecting the knee joint center and the ankle joint center91,92 (Figure 2). It has been 
shown to provide excellent reliability when measured with digital software programs93,94. 
13 
 
 
 
 
 
Figure 2: A) The mechanical axis angle (MAA) of the lower limb is measured as the 
angle between the line connecting the center of the hip and knee joints and the line 
connecting the center of the knee and ankle joints. B) The weight-bearing line 
(WBL) is drawn from the center of the hip joint to the center of the ankle joint. 
 
 
 
A B 
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Based on the MAA measure, lower limb alignment can be assessed to identify patients 
with varus (“bow-legged”) or valgus (“knock-kneed”) alignment. Individuals with an 
inward angulation of the distal segment of the lower limb (tibia and fibula) and a negative 
MAA are considered varus aligned, while those with an outward angulation and a 
positive MAA are considered valgus aligned. Many epidemiological studies suggest that 
lower limb malalignment is an important risk factor for knee OA progression5,55,76,95,96 
and that the direction of this malalignment will affect which compartment of the knee 
joint is most affected. Medial compartment knee OA is most often seen in individuals 
with varus alignment, whereas lateral compartment knee OA is more commonly seen in 
individuals with valgus alignment55,76,97,98. 
The role alignment plays in the degenerative process of medial knee OA is related to 
increased loading of the knee joint10,96,99. The distribution of loading within the joint is 
related to the lower limb weight-bearing line (WBL), a line drawn from the center of the 
femoral head to the center of the ankle (Figure 2). Individuals who are neutrally aligned 
will bear 75% of the overall knee load in the medial compartment while standing on one 
leg91 with a WBL passing through the medial compartment of the joint. As alignment 
steers away from neutral and the WBL is shifted medially, the load distribution within the 
knee joint will undergo aberrant changes. Individuals with varus alignment will 
experience an increase in medial compartment loading9,91,100. This in turn, will lead to a 
heightened degree of articular cartilage degeneration. In fact, a longitudinal study found 
that for every additional 1 degree of varus, patients will lose 17.7µl of femoral articular 
cartilage on average annually, with similar losses seen in the tibial cartilage volume97.  
Overall, the increase in compartmental loading associated with varus alignment promotes 
progression of medial compartment knee OA. The additional loading intensifies medial 
articular degeneration and loss which results in medial joint space narrowing, a further 
degree of varus alignment and additional loading in the medial compartment, creating a 
vicious cycle of medial compartment knee OA progression (Figure 3). 
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Figure 3: The “vicious cycle” of medial compartment knee osteoarthritis. Varus 
alignment leads to excess loading on the medial compartment, promotes articular 
cartilage breakdown, narrowing of medial joint space and further malalignment of 
the joint. 
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1.3.2.4.2 Gait and Knee Osteoarthritis  
For the general population, one of the most common daily activities performed is 
walking, with thousands of steps taken per day101. Three-dimensional (3D) motion 
analysis of gait kinematics and kinetics has been used extensively in the literature to 
better understand biomechanical factors associated with knee OA. Specifically, authors 
have investigated the role of the external knee adduction moment (KAM) (Figure 4) on 
increased loading of the medial compartment10,102,103. During stance phase of gait, 
individuals will generate a ground reaction force (GRF) vector that projects upwards and 
medial to the knee joint’s center of rotation. The perpendicular line that connects the 
GRF to the knee joint center is known as the lever arm and the product of this lever arm 
and the GRF vector generates what is known as the external KAM. The external KAM 
creates a torque force that causes the tibia to adduct in relation to the femur, which results 
in greater compressive loading to the medial compartment of the joint. As the GRF is 
projected more medially, the lever arm grows longer and thus, increases the magnitude of 
the external KAM suggesting that the increase in external KAM is also related to 
alignment. Halder at al. suggest that the magnitude of medial compartment loading 
increases 5% for every 1 degree increase in varus while walking104. 
Several studies have shown that the external KAM is strongly associated with 
characteristics of knee OA such as knee pain in previously asymptomatic knees88 and 
measures of OA disease severity87,105. It has also been proven to be a reliable, valid and 
clinically meaningful proxy measure of medial compartment loading during gait9,106,107 
and more importantly, a predictor for OA disease progression10,89. Thus, treatment 
strategies have been geared towards decreasing the magnitude of external KAM during 
walking in an attempt to slow disease progression. 
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Figure 4: The external knee adduction moment (KAM) about the knee is the 
product of the perpendicular distance between the knee joint center and the ground 
reaction force (GRF) vector in the front plane, forming the lever arm, and the 
magnitude of the GRF vector. Figure adapted from Perry J Gait Analysis: Normal 
and Pathological Function 1992108. 
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1.3.2.5 Diagnosis and Clinical Manifestations 
Knee OA can develop in one or more of the three knee joint compartments: the medial 
tibiofemoral joint, the lateral tibiofemoral joint or the patellofemoral joint. Clinicians will 
use both clinical and radiographic assessment to diagnose patients with knee OA. Often, 
clinical assessment follows the guidelines set by Altman et al.109, while radiographic 
assessment follows the criteria set by Kellgren and Lawrence110 (Figure 1). According to 
Altman et al., the required clinical criteria to diagnose a patient with knee OA includes 
knee pain,  as well as one of the following; crepitus (popping sound/sensation or 
cracking) of the joint, over 50 years of age, or morning stiffness that lasts no longer than 
30 minutes. For radiographic assessment, Kellgren and Lawrence developed a four point 
joint degeneration rating scale (1 = mild OA, 4 = severe OA) to assess OA disease 
severity in the knee joint by evaluating the presence or absence of osteophytic bone, 
sclerosis of subchondral bone and whether marked joint space narrowing is present on 
anteroposterior radiographs. Lateral and skyline radiographic views can also be helpful in 
confirming compartment disease severity111. 
Patients diagnosed with knee OA can exhibit a number of clinical symptoms which 
include recurrent joint pain (frequently activity-induced and persistent), stiffness, and 
swelling, reduced function, reduced range of motion, crepitus and deformity109,112. Often, 
these symptoms will limit individuals and restrict participation in their daily activities113 
and often makes them more dependent on others when it comes to walking, climbing 
stairs and performing lower extremity activities. Therefore, it is of utmost importance to 
identify treatment interventions that are geared towards minimizing pain, symptoms and 
function for patients with knee OA.  
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1.3.3 Management of medial compartment knee OA 
Currently, there is no established cure for OA. However, a number of treatment 
modalities are available to aid patients in the management of associated pain and 
symptoms. Clinical guidelines outline non-surgical and surgical treatment interventions 
for patients with symptomatic knee OA1,114. Available non-surgical interventions include 
physiotherapy, pharmacotherapy, foot orthoses, bracing, lifestyle modifications and 
activity management. These modalities typically target symptom management, but do not 
alter joint anatomy and benefits are not considered to be permanent. Surgical 
interventions include high tibial osteotomy (HTO), unicompartmental knee arthroplasty 
(UKA) and total knee arthroplasty (TKA). These modalities physically alter joint bony 
structures with permanent anatomical changes which modify risk factors that promote 
knee OA disease progression such as knee malalignment. Ultimately, selection of 
management method is decided upon mutually between the clinician and the patient 
based on the patient’s personal characteristics, physical functional limitations, symptom 
severity and the current level of disease severity. 
For patients in earlier stages of the disease, clinicians typically attempt non-surgical 
interventions before opting for surgery. However, patients who are at more progressed 
stages of the disease often display substantial mobility restrictions, severe pain, decreases 
in quality of life and severe degenerative changes in a single or multiple compartments of 
the knee warranting a referral to an orthopaedic surgeon. The surgeon may recommend a 
UKA or a TKA to replace the articular components of the joint or the surgeon may 
recommend a HTO to correct malalignment of the lower limb, a risk factor for 
progression of OA, while preserving the components of the joint. All three surgical 
procedures have shown evidence of long-term benefits for pain management, improved 
quality of life and mobility, but differ in terms of recovery time, invasiveness, potential 
adverse events, limitations in activity participation following surgery and costs associated 
with the procedures115–119. Thus, selection of the appropriate surgical intervention must 
be done carefully in order to maximize the probability of successful outcomes following 
surgery. 
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1.3.4 Medial Opening Wedge High Tibial Osteotomy  
Medial opening-wedge high tibial osteotomy is a surgical treatment for patients with 
varus alignment of the lower limb and medial compartment knee OA15,19,20,120. The 
procedure corrects knee malalignment by shifting the weight-bearing load of the joint 
laterally to a more neutral position (usually slight valgus) and away from the affected 
portion of the knee (Figure 5) 121. The redistribution of load decreases the magnitude of 
both static (standing) and dynamic (during walking) loading in the medial compartment 
with the goal of relieving patient symptoms and slowing the progression of the 
disease95,122.  
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Figure 5: Patient radiographs (A) before and (B) 12 months after HTO surgery. The 
yellow lines provide an estimate of the weight-bearing line (WBL) to display the 
shift to a more neutral position. 
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1.3.4.1 Preoperative Assessment 
Similar to consideration in other surgical procedures, surgeons take a thorough patient 
history that identifies previous lower limb injuries or comorbidities that would 
contraindicate the patient from undergoing surgery and help ensure patient compliance 
during the post-operative period. A physical examination is then conducted to identify 
ligamentous instabilities of the joint and to provide additional information to aid the 
surgeon in establishing an appropriate treatment plan. Previous authors suggest the 
surgery is ideally performed on healthy young, active patients, where the level of joint 
degeneration is isolated to the medial compartment with associated varus alignment as 
determined by the mechanical axis angle19,111,121. It is usually recommended to patients 
whose activities of daily living are typically more physically demanding. Inactive patients 
with tricompartmental disease, have complaints of rest/ night pain and those who are 
above 60 years of age may be better suited for a TKA121. Appropriate patient selection is 
considered crucial to maximize the likelihood that the procedure will be successful120. 
Ideal patient criteria for medial opening wedge HTO is presented in Table 1. 
 
Table 1: Ideal patient criteria for a medial opening wedge HTO. 
Varus deformity of the lower limb 
Pronounced degeneration in the medial compartment of the  
     tibiofemoral joint  
Moderate to high activity levels 
Younger than 60 years of age 
 A certain degree of pain tolerance 
Symptoms of instability are not considered a contra-indication 
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Radiographic assessment is considered an important component for preoperative 
planning20,120 with full-limb standing anteroposterior (AP) radiographs111,123. Radiographs 
are used to determine the patient’s MAA and anatomical axes of the femur and tibia, as 
well as identifying the degree of arthritic joint degeneration in both the medial and lateral 
compartments of the joint. Ultimately, the AP radiographs are used to calculate the 
suggested degree of surgical correction for the procedure. Using the technique described 
by Dudgale et al., the desired correction has the WBL shifting laterally to a maximum 
position of 62.5% of the medial-to-lateral tibial plateau width, otherwise known as the 
“Fujisawa point” 124.  
 
1.3.4.2 Surgical Procedure 
The classic technique for a medial opening wedge HTO has previously been described by 
Amendola and Fowler20,120. First, a guide pin is drilled medially into the proximal tibia at 
an angle approximately 3cm below the medial joint line. An oscillating saw is then used 
to make surgical cuts medially, anteriorly and posteriorly into the proximal tibia where 
both flexible and rigid osteotomes are used to complete the osteotomy and open the 
wedge to a predetermined correction size. Once achieved, the proximal and distal 
portions of the bone are fixed with an internal fixation plate using both cancellous and 
cortical screws. Bone graft or a synthetic substitute is typically used to fill in the wedge 
space for corrections larger than 7.5mm to assist with the bone healing process20,125. The 
surgery is done under fluoroscopic control to ensure that the desired correction is 
accurately achieved and to avoid breaching the lateral tibial cortex when making the cut. 
Often, surgeons will also perform knee arthroscopy preceding the HTO to investigate OA 
severity in both the medial and lateral compartments of the tibiofemoral joint. The degree 
of degeneration in the lateral compartment is important to consider as shifting the loading 
from the affected medial compartment to a lateral compartment that is equally as 
degenerated may affect the success or longevity of the procedure. In such cases, surgeons 
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must decide whether proceeding with the HTO is in the best interest for the patient. 
Arthroscopy also allows a full visual inspection of the joint entirely to examine the 
overall knee condition and to surgically treat unstable chondral or meniscal tissue if the 
surgeon feels that it is indicated120.  
Following surgery, patients are monitored during their rehabilitation and given early joint 
exercises. These exercises are geared towards retraining patient gait, improving their 
range of motion, managing pain and improving overall function. Patients undergo a 
progressive returning to weight-bearing protocol based on evidence of radiographic bone 
healing and subsidized pain. 
 
1.3.4.3 Benefits of Medial Opening Wedge HTO 
The most common surgical methods of HTO reported in the literature are the medial 
opening wedge HTO and the lateral closing wedge HTO. Between these techniques, 
medial opening wedge HTO has grown in popularity over the last few years126. The 
method easily allows simultaneous bi-planar correction of the frontal and sagittal planes 
to correct limb alignment. The ability to increase the wedge opening gradually to the 
desired correction also allows for a more precise adjustment in both the frontal and 
sagittal planes and makes it easier to achieve smaller corrections (< 5 degrees) than in a 
lateral closing wedge HTO20. Moreover, the lateral closing wedge HTO requires two cuts 
to be made in the bone which can make it difficult to achieve the proper correction size 
and to form opposing bone surfaces that easily articulate to facilitate bone healing127.  
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1.3.4.4 Medial Opening Wedge HTO Success 
Many studies have shown that medial opening wedge HTO is beneficial to the patient 
both clinically and biomechanically. Measures of pain, symptoms, function and quality of 
life have all been shown to improve significantly at one to five year follow-up 
assessments after the procedure27,28,122,128–130. It has also been shown to reduce the level 
of loading on the medial compartment of the knee joint by significantly decreasing the 
degree of malalignment122,131 and reducing the external knee adduction moment during 
ambulation28,95,122,128,131 as well as other relevant kinematic and kinetic measures such as 
varus thrust90 that promote disease progression. Overall, medial opening wedge HTO is 
suggested to be a successful procedure with survival rates reported as high as 98% after 
five years132, 90% after ten years133 and 71% after 15 years132  following the HTO. 
Despite the many benefits of HTO, there are a number of complications associated with 
the surgery. Reports of surgical complications vary between authors, ranging from 1% to 
45% of cases24,126,134–139. The most frequently reported are lateral cortex hinge fractures, 
hardware failure often resulting in loss of correction, delayed and non-union of the bone 
(insufficient healing of the fracture site after a given time lapse) and hardware failure. 
However, many authors suggest that the rate of complication is dependent on the type of 
internal fixation used for the procedure37,38,126,134,140,141. 
 
1.3.4.5 Weight-bearing and Return to Work after HTO 
Postoperative care following medial opening wedge HTO typically involves a 2 week 
period of toe-touch or feather weight -bearing with limb stabilization from a tracker 
brace, followed by a progressive increase in weight-bearing to the surgeon’s discretion 
based on radiographic healing of the bone and knee pain. The typical progression would 
have patients graduate to toe-touch or feather-touch weight-bearing, followed by 
protective (or partial, progressive) weight-bearing with crutches, to weight-bearing as 
tolerated and finally, full weight-bearing without crutches. 
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The length of time for protected weight-bearing ranges between two and 12 weeks24–30,142. 
A return to full weight-bearing without gait aid (i.e. crutches, cane, walker, etc.) after 
HTO surgery is dependent on the ability of the bone to consolidate enough to safely bear 
weight on the limb. This is a major concern for surgeons, as allowing patients to early 
weight-bear after HTO has the potential to increase complication rates if the plate does 
not provide enough stability. As a result, studies have shown that the return to weight-
bearing process can be related to the type of fixation hardware used for the HTO37.  
Optimized stable implant designs are therefore essential to warrant a safe earlier return to 
weight-bear. 
Another important factor to consider associated with the time to return to weight-bearing 
is the time to return to work following the HTO. Time lost from employment and leisure 
accounts for an estimated 80% of the overall annual costs for OA in Canada143. It is 
important for healthcare providers to target OA treatment interventions that minimize 
these productivity losses to society and help reduce the overall OA burden worldwide. 
Previous studies have reported that the time to return to work following medial opening 
wedge HTO ranges between three to six months142,144–146. It is important that more stable 
plate designs are developed to allow patients to return to weight-bearing earlier, 
translating to a faster return to work which will benefit society as a whole.  
 
1.3.4.6 Locking Plate vs. Non-Locking Plate Designs 
Early studies suggest that an optimal balance between micro-motion and implant stability 
is needed to promote osteotomy healing147,148 by ensuring that the plate is not too stiff 
(suppresses micro-motion and healing149) but is stable enough to evade non-union of the 
osteotomy site. Over the years, technological advancements have allowed manufacturers 
to design fixation plates that provide the required components to optimize HTO success. 
Fixation plates used in HTO can generally be divided into non-locking and locking plate 
categories. Conventional non-locking plates were designed to provide stability to the 
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osteotomy with resistance to various types of loading33. The force generated from the 
axial load is countered by the normal force of the plate (i.e. the product of the friction 
force between the plate and bone, and the force generated by screw torque) which forms a 
shear stress at the bone-plate interface. As the screw torque or the friction coefficient 
decreases however, bone-plate motion increases. Excessive motion results in mechanical 
environment that discourages primary or secondary bone healing.  Furthermore, frictional 
forces that are overcome by axial loading rely on the axial stiffness of the screw most 
distal to the plate to maintain stability. The lack of axial control in non-locking screws 
forces it to be maintained by the bone at the bone-plate interface. Here, the bone is the 
load-determining factor in maintaining stability under compressive loads. The high 
mechanical shear stresses generated therefore leaves the bone vulnerable to failure under 
compressive load or susceptible to absorption of the bone that results in screw loosening. 
Since, locking plate designs have been developed to address the mechanical pitfalls of 
conventional non-locking plates. Locking plates control the axial orientation of the 
screws to the plate, which improves bone-plate-screw stability33. Locking screw-plate 
constructs act as fixed-angle devices that provide stability maintenance without relying 
on bone-plate friction and can convert shear stresses to compressive stresses when subject 
to loading. This improves the stability of the fixation as bone has a high resistance to 
compressive stress and a low tolerance for shear stress. The strength of the fixation also 
combines the strength of all bone-screw interfaces, as opposed to relying on the axial 
stiffness of a single screw (i.e. in non-locking plates), which further increases the stability 
of the implant150. Additionally, threaded locking screws or interference washers provide 
angular and axial stability that optimize the rigidity of the fixation and optimized strain 
under loading conditions. The latter provides a favourable biological environment for 
secondary bone healing with callus formation, important for fractures located in the 
metaphysis (Schutz, 2003) such as the case in the proximal tibia after HTO. The lack of 
frictional forces between the bone and plate also allows blood supply under the plate to 
be preserved and is suggested to promote faster bone healing151.  
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Although all fixation plate designs have the same goal of maintaining correction size and 
promoting bone healing, the mechanical and biological benefits that locking plates 
provide are suggested to optimize rehabilitation outcomes after HTO surgery 27,127,152. 
Many studies have evaluated different plate designs through biomechanics and clinical 
outcomes23,29,34–38,42,43,140,141,153,154. General conclusions suggest that locking plates provide 
better stability for patients with a higher resistance to mechanical stresses35 and optimized 
micro-motion at the osteotomy site23. Locking plates are also suggested to allow patients 
to return to full weight-bearing and achieve consolidation of the osteotomy faster37, 
improve clinical outcomes faster37,141, and reduce the cases of delayed and non-union22,38, 
hardware failure41, loss of correction41,155 and post-surgical lateral cortex fractures38 than 
using a non-locking plate.  
 
1.3.5 The Arthrex ContourLock HTO Plate®  
The Arthrex ContourLock HTO Plate® is a new titanium fixation device designed with a 
locking construct (Figure 6), an anatomically curved body, a wider frame than previously 
introduced locking plates and screws that diverge proximally. To date, no studies have 
compared clinical outcomes between the Arthrex ContourLock HTO Plate® and other 
more conventionally used plate designs. However, a few studies have examined the 
biomechanical differences between the Arthrex ContourLock HTO Plate® and other 
implants.  
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Figure 6: A) The Arthrex ContourLock HTO Plate® design (Arthrex, Naples, FL) 
possesses a wide frame which lengthens the distance between fixation screws and 
provides additional stability. B) & C) Top and side views of the Arthrex 
ContourLock HTO Plate® illustrate the anatomically curved body of the implant. 
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Studies have shown that the Arthrex ContourLock HTO Plate® provides great stability 
under static loading, similar to other implant designs (Tomofix sm, Tomofix std, 
iBalance, Peek Power), while it provides superior stability under dynamic cyclic loading 
conditions, likely as a result of a wider frame and larger distance between fixation 
screws42,43. Although these studies suggest that the maximum forces at moment of failure 
are considered too low to warrant full dynamic loading (full weight-bearing) immediately 
after the surgery for all the plate designs studied, the maximum force at failure for the 
Arthrex ContourLock HTO Plate® is almost twice as high as other designs, suggesting 
that full dynamic loading may be achievable for patients much earlier and would require 
less healing of the osteotomy site to safely begin weight-bearing. Furthermore, a study 
using finite element modeling showed that at higher compressive loadings, the Arthrex 
ContourLock HTO Plate® experiences low hardware stresses and small wedge 
micromotion which can be beneficial for fracture site healing156. 
Although there is currently only a small body of evidence to support the use of the 
Arthrex ContourLock HTO Plate® design, the aforementioned biomechanical studies 
suggest that the Arthrex ContourLock HTO Plate® is a great implant choice for patients 
who require a strong, stable locking construct for an early return to weight-bearing 
following the HTO surgery. A faster return to full weight-bearing could translate to faster 
improvements in clinical outcomes relating to pain, symptoms and quality of life for the 
patient, as well as faster returns to daily activity and sport. In turn, patients could return 
to work much earlier, which would provide socioeconomically benefit by reducing losses 
in productivity in the workforce. 
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1.3.6 Health Economics 
Healthcare costs are rising at an alarming rate. The current economic climate requires a 
high level of accountability from budgetary decision-makers for expended healthcare 
dollars157. As a result, decision-makers are seeking treatment interventions that provide 
the best quality of care for patients while minimizing dollars spent for the intervention. 
Programs are now requesting evidence-based research to support the economic efficiency 
of treatments to better judge the value for their money158.  
 
1.3.6.1 Economic Evaluation 
Economic evaluation provides a framework to compare clinical and cost data 
simultaneously between competing interventions to assess value for money159. In Canada, 
along with many other countries, economic analyses are a requirement for manufacturers 
wishing to make their products available as treatment options with Ontario’s Health 
Insurance Plan160. They are also a useful evaluative tool for decision-makers operating on 
a given budget in order to make choices concerning the deployment of finances for 
maximum health benefit. 
 
1.3.6.2 Economic Burden of Osteoarthritis 
Symptoms of OA typically do not resolve, and are associated with chronic pain that can 
persist for decades, resulting in a substantial number of health-care visits over a lifetime, 
which poses a large economic burden on healthcare systems. In industrialized countries 
such as Canada, the US, UK, Australia and France, OA accounts for anywhere between 1 
and 2.5% of the country’s gross national product161. In Canada alone, there is an average 
annual cost of $12,200 ($CAN) per patient with OA143 with the annual economic burden 
of OA estimated to increase to $405 billion dollars by 202049. As the burden of OA 
continues to grow around the world, health care systems are in critical need of identifying 
treatment interventions that limit OA progression at a minimal cost. 
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1.3.6.2.1 Cost-Effectiveness of Medial Opening Wedge HTO 
Medial opening wedge HTO is a procedure that has been shown to benefit patients with 
varus alignment and medial compartment knee OA both clinically and biomechanically 
however, economic evaluation of the HTO procedure is an evolving area of research. 
Studies are beginning to examine the economic impact of medial opening wedge HTO in 
comparison to alternative treatment methods. 
The first study to evaluate the cost-utility of HTO concluded that UKA is a more cost-
effective treatment method for medial compartment knee OA than HTO162 (Brown, 
2010). A study that soon followed found results favoring the KineSpring® Knee Implant 
System (an implantable load absorber)163. However, the authors from this study claim to 
report an ICER when the values reported are in fact average cost-effectiveness ratios 
(ACERs). This incorrect use of terminology can lead to misinterpretation of results164 and 
inaccurate conclusions.   
More recently, two studies have investigated the cost-utility of HTO compared to both 
UKA and total knee arthroplasty (TKA) for younger patients with medial compartment 
knee OA118,119. According to the results of these studies, HTO is the most cost-effective 
treatment for patients below 60 years of age and the authors strongly support the use of 
HTO as a first line treatment method for this younger patient population.  
The aforementioned studies provide some evidence to suggest that HTO is a cost-
effective treatment intervention for patients who are varus aligned and with medial 
compartment knee OA. However, no studies have been conducted to compare economic 
impact of using different internal hardware devices when performing a medial opening 
wedge HTO surgery. Locking plates have been suggested to provide functional and 
patient-important benefits when compared to non-locking plates for medial opening 
wedge HTO35,36,43 and are thought to reduce the number of post-operative complications 
(i.e. non-union) that can result in revision surgery37,38,141. Patients are also expected to 
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return to full weight-bearing sooner, and therefore productivity losses may be lessened by 
allowing patients to return to work sooner. In both cases, costs associated with the 
surgery can be minimized. However, locking plates and screws are generally more 
expensive than non-locking designs, and the bulkiness of locking plates can be irritating 
to the patient requiring surgical plate removal29,40,44 further increasing the costs 
associated with the procedure. Cost-effectiveness analysis is therefore warranted to 
justify using locking plates for medial opening wedge HTO. 
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Chapter 2  
2 Methods 
2.1 Study Design 
We conducted a retrospective analysis using prospectively collected data from patients 
who had undergone medial opening wedge HTO at the Fowler Kennedy Sport Medicine 
Clinic between July 2005 and June 2015, performed by one fellowship-trained 
orthopaedic surgeon (JRG). All surgeries were completed using either a locking (Arthrex 
ContourLock HTO Plate®) or a non-locking (Arthrex Puddu Plate®) internal fixation 
plate. Patients at earlier time points of the study received the non-locking plate. 
Availability of the locking plate in 2009 resulted in a shift in clinical practice where most 
patients received the locking plate. The study was approved by the University of Western 
Ontario’s Research Ethics Board for Health Sciences Research Involving Human 
Subjects. All patients had provided informed consent prior to study enrollment to have 
their data entered into a research database. 
 
2.2 Eligibility Criteria 
We included patients who underwent a medial opening wedge HTO for mechanical varus 
alignment and had been diagnosed with knee OA according to the American College of 
Rheumatology classification criteria109 affecting primarily the medial compartment of the 
tibiofemoral joint. We did not exclude patients with evidence of lateral compartment 
knee OA as long as the patient’s symptoms and radiographic severity of OA was more 
pronounced in the medial compartment. We excluded patients who had a combined HTO 
and anterior cruciate ligament (ACL) reconstruction, as well as those who received a 
bilateral HTO. We also excluded patients that underwent a revision ACL reconstruction 
surgery on the same limb or an HTO on the contralateral limb within 12 months 
following surgery. 
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2.3 Intervention 
2.3.1 Operative Procedure 
Preoperative hip-knee-ankle full-limb standing anteroposterior radiographic views were 
used to calculate the desired correction size for the osteotomy using the method described 
by Dugdale et al.124 This technique suggests a shift in the weight-bearing line to 62.5% of 
the medial-to-lateral tibial plateau width. Other considerations for preoperative 
templating were the condition of the articular cartilage in the lateral compartment and the 
degree of correction required to achieve neutral alignment. 
The HTO was performed using a medial opening wedge technique similar to the 
procedure described by Fowler et al.20 Fluoroscopy was used to insert a guide pin and 
osteotomes, both flexible and rigid, were used to perform the osteotomy. Once the tibia 
was opened to the desired width, fluoroscopy was again used to confirm correction size 
and limb alignment. If necessary, adjustments were made to the posterior tibial slope to 
provide address sagittal instability. One of two plate designs was used as an internal 
implant: a 4-hole Arthrex Puddu Plate® non-locking plate (Arthrex, Naples, FL, USA) or 
an Arthrex ContourLock HTO Plate® locking plate (Arthrex, Naples, FL, USA). Cortical 
and cancellous bone screws were used to fixate the osteotomy both proximally and 
distally and confirmed using fluoroscopy. For corrections larger than 7.5mm, cancellous 
bone allograft was used to fill in the osteotomy gap. 
 
2.3.2 Post-operative Care 
Following surgery, the operative limb was placed in a hinged knee brace. At this time, 
patients were instructed to feather-touch weight-bear (WB) with the assistance of 
crutches for a minimum of two weeks. Once the patient showed clinical and radiographic 
evidence of osteotomy healing, they progressed to protective WB.The decision to 
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progress   the weight-bearing status of the patient during rehabilition was decided by the 
surgeon using radiographic evidence of osteotomy healing (i.e. the extent of 
consolidation on x-ray), perceived stability of the fixation device and the level of pain or 
discomfort reported by the patient during ambulation. 
 Patients were also given a progressive rehabilitation protocol to allow them to re-
establish full range of motion, strength and function, in addition to reducing swelling, and 
avoiding joint contracture and muscle atrophy from disuse. Patients began this program at 
three weeks postoperative with lighter exercises and progressed in exercise difficulty 
until they exhibited a normal gait pattern at the discretion of the physiotherapist. All 
patients followed the same rehabilitation protocol with slight modifications if deemed 
necessary. 
All patients returned to clinic for a follow-up visit with the surgeon at two and six weeks 
and three, six and 12 months after surgery. Patients who experienced intraoperative or 
post-operative complications (i.e. infection, delayed union, etc.) were reviewed as 
needed. 
 
2.4 Radiographic Assessment 
A full-limb standing digital radiograph of the lower limb was obtained for each patient at 
baseline, three, six and 12 months following surgery. Patients stood with patellae 
centered over their femoral condyles with feet pointed straight ahead. The position 
controls for effects of foot rotation on alignment measures that could result in inaccurate 
frontal plane images165. Additional imaging was taken for patients who displayed delayed 
bone healing and/or suspected complication to monitor consolidation more closely. 
Baseline radiographs were assessed using a customized computer software program 
(HTO Pro; Wolf Orthopaedic Biomechanics Laboratory, London, Ontario, Canada)93. 
Anteroposterior radiographs were measured to obtain the preoperative mechanical axis 
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angle (MAA) and to assess OA severity in both the medial and lateral tibiofemoral 
compartments. The MAA was defined as the angle generated between the mechanical 
axis of the femur and the mechanical axis of the tibia91,166. In other words, it is the angle 
formed by the lines connecting the center of the hip to center of the knee, and the center 
of the knee to the center of the ankle. The center of the hip was characterized as the 
center of a circular outline positioned over the femoral head. The center of the knee was 
characterized as the midpoint of a line drawn between the peaks of the tibial spines, 
extrapolated inferiorly to the surface of the intercondylar eminence. The center of the 
ankle was characterized as the midpoint between the fibula and tibia at the height of the 
tibial plafond. A negative MAA value indicated varus alignment. Previous studies 
conducted in our lab have shown excellent reliability for the MAA when using the 
HTOPro program (ICC2,1 = 0.97)93. Joint degeneration in the medial and lateral 
compartments of the tibiofemoral joint was measured using the Kellgren-Lawrence rating 
scale110. Although the reliability of reporting the Kellgren-Lawrence grade using HTOPro 
has not yet been reported, evaluators were given original atlases of individual 
radiographic features for Kellgren-Lawrence grading of knee OA. These guidelines have 
proven to be reliable in measuring the severity of knee OA. 
 
2.5 Outcome Measures 
2.5.1 Return to full weight-bearing 
We defined time to return to full weight-bearing as the time to discontinuation of gait aid 
use (i.e. crutches, cane, or walker), as documented in the medical record. A single 
reviewer (CAP) reviewed patient clinic follow-up reports from each follow up visit time 
point up to 12 months following the HTO. Identified weight-bearing status terms 
included non-weight-bearing, toe-touch (or touch-down, feather-touch) weight-bearing, 
partial (or progressive, protective) weight-bearing, weight-bearing as tolerated and full 
weight-bearing. Discontinuation of gait aid use (i.e. crutch, cane, or walker) was outlined 
as surgeon instruction to wean off of crutches (or slowly wean off) or a report that the 
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patient was ambulating without the use of crutches (or other gait aid). A weight-bearing 
status timeline was created for each patient to determine the total time it took for each 
patient to return to full weight-bearing without use of a gait aid. The total time to return 
to weight-bearing was expressed in weeks. 
If the time to return to full weight-bearing was specified by the surgeon, the time from 
surgery to that appointment date was attributed as the total time to return to weight-
bearing for the patient. For patients whose reports did not explicitly provide a value in 
weeks, we made assumptions to determine total return to weight-bearing time. Patients 
were given a time to return to full weight-bearing one week past the date of the follow-up 
visit if they were instructed to wean off of their crutches and were fully weight-bearing 
by their next appointment. Similarly, patients instructed to slowly wean off crutches were 
attributed a time to return to weight-bearing two weeks later than the date of the follow-
up visit. A patient who was described as having already been off crutches was attributed a 
return to weight-bearing time one week earlier than said appointment as a conservative 
measure. If the surgeon specified exactly how many weeks earlier that they were off 
crutches, that value was assigned to the patient. 
In cases where the patient missed an appointment visit and the time to return to weight-
bearing was unclear, a conservative measure of worst possible outcome was attributed to 
that patient. For example, if a patient was still on crutches at 10 weeks, was not seen at 3 
months, but was off crutches at a 4 month appointment visit, the given outcome value 
was one week earlier than the 4 month appointment date (i.e. 16 weeks). 
 
2.5.2 Knee injury and Osteoarthritis Outcome Score 
The Knee injury and Osteoarthritis Outcome Score (KOOS) is a 42-item self-
administered knee and OA-specific questionnaire that addresses five domains of health: 
pain (9 items), other symptoms (7 items), function during activities of daily living (17 
items), function during sport and recreational activities (5 items), and quality of life 
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related to the knee (4 items). The tool uses a five-point ordinal scale for each item and 
generates a standardized mean value score to represent each of the five domains ranging 
from 0 (worst outcome) to 100 (best outcome). The KOOS has been shown to exhibit 
excellent test-retest reliability in each domain (range 0.75-0.93), face validity, construct 
validity and responsiveness to change for individuals with knee OA and ligamentous 
injuries167,168.  A change of ten points in a given KOOS domain is considered to be 
clinically meaningful169. 
 
2.5.3 Cost 
2.5.3.1 Surgical Costs 
All direct costs associated with the HTO procedure were reported using the average 
procedure cost from the Ontario Case Costing Initiative170 in addition to costs associated 
with any additional surgeries (e.g. revisions, hardware removals, irrigation and 
debridement for infection). These costs included operating room (OR) costs, equipment 
used, and other medical tests performed during the procedure, as well as the total length 
of stay in the hospital (outpatient or inpatient) following surgery. Surgeon and 
anaesthesiologist billing fees were obtained through the Ontario Ministry of Health 
Schedule of Benefits171. The individual costs for the locking (Arthrex ContourLock HTO 
Plate®) and non-locking (Arthrex Puddu Plate®) plates and their associated fixation 
screws were obtained from our hospital’s cost report data. 
 
2.5.3.2 Healthcare Resource Use 
To account for possible postoperative complications, we recorded any additional 
healthcare resource use for 12 months following the HTO surgery by reviewing patient 
clinic charts and electronic hospital records. All clinic consultations, follow-up visits, 
emergency room visits and hospitalization, diagnostic imaging and laboratory tests 
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performed and additional procedures performed for postoperative complications were 
recorded. Costs were attributed using the Ontario Ministry of Health Schedule of 
Benefits171.   
Additionally, we recorded patient time to return to work. The time to return to work was 
defined as the time loss of employment, retirement or homemaking following surgery. 
The total time was determined in one of two ways. First, if patients returned to the clinic 
for a follow up visit during the study period, they were asked to indicate their 
employment status at the time of surgery, time off work from paid employment (or 
retirement, homemaking activities, etc.) as a result of the HTO, change in employment 
status (i.e. modified or restricted duties), and level of activity of employment. If patients 
did not return to the clinic during the study period, we reviewed the surgeon dictated 
clinic follow-up reports up to 12 months following the HTO to identify the patient’s 
occupation and references of date to return to employment. The total time was reported as 
either below 3 months (with specification of total time), 3-4 months, 5-6 months, 7-8 
months, more than 8 months (with specification of total time) or “I did not return to 
work”.  
The 2015 average Canadian wage reported by Statistics Canada was used to account for 
time off employment172. We assigned the current value of minimum wage in Ontario to 
account for time off for patients who were retired, or who lost time from home making 
activities. 
We estimated the total cost for each individual patient over the study period. All costs 
were reported in 2016 Canadian dollars. 
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2.6 Data Analysis 
We used descriptive statistics to describe the demographic and clinical characteristics for 
each group. We report means and standard deviation (SD) for all continuous measures 
(age, height, mass, body mass index (BMI), mechanical axis angle (MAA)), and 
frequencies and proportions for categorical variables (sex, Kellgren-Lawrence grade and 
American Society of Anesthesiologists (ASA)) (Table1).  All statistical measurements 
were performed using the Statistical Package for the Social Sciences (SPSS) version 23.0 
(IBM SPSS Statistics v 23; IBM Corp, Armonk, New York, USA).  
 
2.6.1 Objective 1 
We conducted an independent t-test to compare the mean between group difference in 
time to return to full weight-bearing with 95% confidence intervals around the estimate.  
 
2.6.2 Objective 2 
We calculated KOOS change scores from baseline to six months after surgery and 
presented the mean and standard deviation (SD) by group for the total KOOS and for 
each KOOS subdomain. We used the six-month time point as our outcome measure since 
stability differences between the plates could affect patient-important outcomes shorter 
term; however, most patients have fully recovered regardless of the plate used by 12 
months after surgery. We compared the mean between group difference in change score 
using an independent t-test and report 95% confidence intervals around the estimates.  
For objectives 1 and 2, we tested the assumptions for independent samples t-test which 
include homogeneity of variance, random independent samples, and normality. Normality 
was tested by plotting a histogram for each outcome and all graphs were assessed for 
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kurtosis and skewness. A Mann-Whitney U non-parametric test was performed if the 
assumption of normality was not met. 
 
2.6.3 Objective 3 
2.6.3.1 Economic Analysis 
We conducted a cost-effectiveness analysis from the healthcare payer and societal 
perspectives. The healthcare payer perspective includes the direct costs from healthcare 
resources consumed including the HTO surgery, any additional procedures (e.g. revision 
surgeries), diagnostic testing and inpatient hospitalizations. The societal perspective 
includes these same costs along with out-of-pocket patient costs (e.g. hyaluronic acid or 
corticosteroid injections) and indirect costs such as time off employment, retirement and 
homemaking activities as a result of the surgery. To capture all costs associated with 
return to work and additional surgical procedures, we included all costs up to 12 months 
following surgery and used the KOOS total change score from baseline to 12 months 
postoperative as our effectiveness measure.  
 
2.6.3.2 Incremental Cost-Effectiveness Ratio 
We calculated the incremental cost-effectiveness ratio (ICER) to consider the value of 
using the locking plate. The ICER is defined as the ratio between the incremental cost 
and the incremental effect (change in KOOS). 
 
2.6.3.3 Net Benefit Regression 
We also estimated the cost-effectiveness of the locking plate using the net benefit 
regression (NBR) framework173, a statistical tool that considers both the incremental cost 
and effect of an intervention in addition to the maximum acceptable amount one is 
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willing-to-pay (WTP) in order to achieve one additional unit improvement in effect. In 
this framework, an intervention is deemed more cost-effective than the existing treatment 
if: 𝐼𝑁𝐵 =𝑊𝑇𝑃 ∗   ∆𝐸 −   ∆𝐶   > 0                                         [1] 
where INB represents the incremental net benefit, WTP is the willingness-to-pay value, 
ΔE is the incremental effect and ΔC is the incremental cost. 
We conducted two individual NBR models to evaluate from both the payer and societal 
perspectives. The WTP values used varied between $0 and $2,000.  The following 
covariates were included in our models: age, sex, BMI, comorbidities and baseline MAA. 
We tested the assumptions for multiple linear regression which include a linear 
relationship between independent and dependent variables, multivariate normality, 
limited multicollinearity, no auto-correlation and homoscedasticity. Linear relationships 
were assessed with scatter plots. Multivariate normality was assessed by plotting 
histograms and all graphs were assessed for kurtosis and skewness. Homoscedasticity 
was assessed by plotting predicted values against the observed values and observing the 
proximity of points to the prediction line. 
 
2.6.3.4 Uncertainty 
To characterize the statistical uncertainty, we presented 95% CIs around our estimates of 
the incremental net benefit (INB) and with a cost-effectiveness acceptability curve 
(CEAC)174.  The CEAC provides a functional representation of probability that the 
treatment is cost-effective at various WTP values.  
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2.6.3.5 Sensitivity Analysis 
We conducted one-way sensitivity analyses on the variables that were considered to have 
the most uncertainty because of the assumptions required to calculate the cost: 1) the 
dollar value for retired or home making time (ranging from $0 per hour to $11.25 per 
hour); 2) adding seven weeks to the return to weight-bearing time for patients where we 
were unable to collect a return to work time and using this value as their time to return to 
work, as seven weeks was the mean time to return to work from return to full weight-
bearing in our sample; 3) combining the adjustments of sensitivity analyses 1 and 2. 
 
2.6.4 Missing Data 
We used Multiple Imputation methods to impute missing 6 and 12 month KOOS total 
change score data. A pooled score was generated from 5 individual imputations to 
provide a best estimate value. Covariates including age, sex, BMI, comorbidities, 
baseline MAA and baseline total KOOS were used in the model to increase the accuracy 
of the imputed values. 
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Chapter 3  
3 Results 
3.1 Patient Flow 
We screened 502 HTO procedures that were captured in our database.  Of these, 249 met 
the inclusion criteria and were included in the present analysis. From this sample, 144 
patients underwent a medial opening wedge HTO using the locking plate, while 105 
patients received the non-locking plate (Figure 7).  
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Number of surgeries by JRG between 
July 2005 and June 2015 (n = 502) 
Excluded (n = 253) 
Reasons for exclusion: 
 Combined HTO/ACL reconstruction (n = 112) 
 Contralateral HTO within 12 months (n = 60) 
Alternative fixation plate (n = 32) 
Lost to follow-up in first 6 months (n = 22) 
 Other HTO procedure performed (n = 21) 
 Staged ACL reconstruction within 6 months (n = 6) 
Included  
(n = 249) 
Locking Plate  
(Arthrex ContourLock HTO 
Plate®, n = 144) 
 
Non-locking Plate 
(Arthrex Puddu Plate®,  
n = 105) 
6-month follow-up (n = 144) 
Baseline (n = 105) 
6-month follow-up (n = 105) 
Baseline (n = 144) 
12-month follow-up (n = 144)* 12-month follow-up (n = 105)* 
Figure 7: Participant flow through the study. Asterisk represents a smaller sample size for the cost-
effectiveness analysis from the societal perspective (n = 106 locking plate, n = 58 non-locking plate). 
47 
 
 
 
 
3.2 Demographics and Clinical Characteristics 
Baseline demographics and clinical characteristics were similar between groups (Table 
2). Patients were typically male, middle-aged and categorized as overweight from their 
BMI. Patients were varus aligned as defined by their MAA and had large correction sizes. 
Most had advanced osteoarthritic degeneration in the medial compartment of the 
tibiofemoral joint, however, the degree of lateral compartment joint degeneration was 
slightly higher in the locking plate group. According to the American Society of 
Anesthesiologists (ASA) score, most patients were considered to have mild systemic 
disease. 
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Table 2 : Baseline demographics and clinical characteristics (n = 249)*. 
Demographic/clinical characteristic 
Group 1: 
Locking Plate	    
(n = 144) 
Group 2: 
Non-locking Plate 
(n = 105) 
Sex, no. (%) 
     Male 
 
108 (75.0) 
 
79 (75.2) 
Age, years 48.9 ± 8.0 46.7 ± 8.6 
Height, cm 175.6 ± 8.3 175.7 ± 9.0 
Mass, kg 92.5 ± 15.3 91.0 ± 17.0 
Body mass index (BMI), kg/m2 30.1 ± 5.0 29.4 ± 4.4 
Operative limb left, no. (%) 77 (53.5) 52 (49.5) 
Mechanical axis angle, degrees a -8.5 ± 2.8 -8.1 ± 3.4 
Mean correction size ± SD (mm) 11.9 ± 2.7 12.3 ± 3.0 
Medial Compartment K/L Grade, no. (%) b   
     1 11 (7.6) 9 (8.6) 
     2 48 (33.3) 28 (26.7) 
     3 61 (42.4) 42 (40.0) 
     4 21 (14.6) 23 (21.9) 
Lateral Compartment K/L Grade, no. (%) b   
     1 25 (17.4) 53 (50.5) 
     2 82 (56.9) 31 (29.5) 
     3 31 (21.5) 10 (9.5) 
     4 0 (0.0) 0 (0.0) 
American Society of Anesthesiologists 
score, no. (%) c 
  
     1 47 (32.6) 37 (35.2) 
     2 83 (57.6) 54 (51.4) 
     3 14 (9.7) 14 (13.3) 
*Values are reported as means with standard deviations unless otherwise specified 
a A negative mechanical axis value indicates varus alignment 
b Kellgren-Lawrence (K/L) grade of osteoarthritis severity 
c American Society of Anesthesiologists physical status classification system: 1 = healthy, normal patient; 2 
= patient with mild systemic disease; 3 = patient with severe systemic disease 
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3.3 Surgical Characteristics 
Diagnostic knee arthroscopy was performed on 246 (98.8%) patients. A tibial tubercle 
osteotomy (TTO) was performed on 130 (52.2%) patients in order to maintain patellar 
height175. Cancellous bone allograft was used to fill the osteotomy for 238 (95.6%) 
patients. Substitute bone grafts used included: cancellous autograft for two patients, 
demineralized bone matrix for one patient and OsteoSet bone graft for one patient. The 
osteotomy was left unfilled in 7 cases (2.8%). Plate removal from a previous HTO on the 
contralateral limb was performed on nine (3.6%) patients (3 non-locking, 6 locking) 
during the procedure and removal of TTO hardware from a previous HTO was performed 
on two (0.8%) patients (2 non-locking). The surgery was an inpatient procedure for most 
cases (228 patients, 91.6%). 
Slight between-group differences were seen in the number of concomitant tibial tubercle 
osteotomy (TTO) surgeries performed (91 patients, 63% locking plate; 39 patients, 37% 
non-locking plate), the number of outpatient cases (19 patients, 13% locking plate; 2 
patients, 2% non-locking) and the number of osteotomies that were left unfilled, with no 
bone graft (1 patients, 1% locking plate; 6 patients, 6% non-locking). These most likely 
represent slight changes in clinical practice of JRG. 
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3.4 Surgical and Post-operative Complications 
A hematoma was noted  in 13 cases. Deep infection was identified in three patients 
requiring an irrigation and debridement surgical procedure to be performed. One patient 
experienced isolated anterior compartment syndrome (likely related to combined TTO), 
which was treated surgically with a fasciotomy. A pulmonary embolism was confirmed 
for one patient with chest radiographs and was treated with thrombolytic medication. A 
deep vein thrombosis (DVT) was documented for one patient through ultrasound and was 
treated with an anticoagulant. Partial implant failure was document in the charts of 12 
patients where ten patients had one broken screw and two patients had two broken 
screws. A partial loss of correction was identified for one patient. One patient 
experienced non-union of the osteotomy site that required a revision osteotomy surgery to 
be performed. A total of 19 patients complained of irritation at site of osteotomy 
following the surgery and had the hardware surgically removed within the first 12 months 
postoperatively. No patients experienced neurovascular injuries or cardiac complications.  
Adverse event rates are summarized in Table 3.  
 
Table 3: Adverse event rates within first 12 months after HTO (n = 249).* 
Complication Group 1: Locking Plate   (n = 144) 
Group 2: Non-locking Plate  
(n = 105)  
Hematoma 3 (2.1%) 9 (8.6%) 
Deep infection 3 (2.1%) 0 (0.0%) 
Compartment syndrome 1 (0.7%) 0 (0.0%) 
Pulmonary embolism 1 (0.7%) 0 (0.0%) 
Deep vein thrombosis 
(documented) 1 (0.7%) 0 (0.0%) 
Hardware failure        1 broken screw 3 (2.1%) 7 (6.7%) 
     2 broken screws 1 (0.7%) 1 (1.0%) 
Partial loss of correction 1 (0.7%) 0 (0.0%) 
Non-union/collapse 0 (0.0%) 1 (1.0%) 
Hardware removal 11 (8.3%) 8 (7.6%) 
Neurovascular injury 0 (0.0%) 0 (0.0%) 
Cardiac complications 0 (0.0%) 0 (0.0%) 
*Values are reported as frequencies with proportions  
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3.5 Outcome Measures 
3.5.1 Objective 1 
There was a statistically significant difference between treatment groups in the time to 
return to full weight-bearing with discontinuation of gait aid (mean difference 6.1 weeks; 
95% CI 4.5, 7.6), with a faster return to weight-bearing for the locking plate group (Table 
4, Figure 8).  
 
3.5.2 Objective 2 
Although the KOOS total change score and subdomain change scores were slightly 
higher in the locking plate group from baseline to six months after surgery, no significant 
between-group differences were found (Table 4, Figure 9). Large improvements were 
seen for both groups from baseline to six months in the total KOOS and all subdomains, 
above the minimal clinically important difference (MCID) of ten points176. Missing 6-
month data values were imputed for 17 patients in the locking plate group (11.8%) and 11 
patients in the non-locking plate group (10.5%). 
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Table 4: Time to return to weight-bearing and patient reported outcome measures 
(KOOS) for all patients (n = 244)*. 
*Values are reported as means with standard deviations 
a The change in KOOS score between baseline and 6 months after surgery 
b A positive mean difference favors the locking plate treatment group 
c A negative mean difference favors the locking plate treatment group 
† p < 0.05, ‡ p ≤ 0.001 
Abbreviations: KOOS = Knee injury and Osteoarthritis Outcome Score, ADL = Activities of Daily Living, 
CI = confidence interval, WB = weight-bearing 
 
 
 
Outcome 
Time (weeks) 
p-value Locking Plate  
(n = 144) 
Non-locking Plate 
(n = 105) 
Time to return to WB 10.9 ± 5.8 17.0 ± 6.5 <0.01‡ 
KOOS 
Outcome 
(range 0 – 
100) 
Time point 
Treatment Group 
Mean Difference c 
(95% CI) p-value Locking Plate  (n = 144) 
Non-locking Plate 
(n = 105) 
Pain Baseline 52.0 ± 19.9 52.6 ± 18.5   
 6-month 70.1 ± 17.7 68.5 ± 17.6   
 Change Score a 18.3 ± 20.7 15.9 ± 20.6 -2.4 (-8.1, 3.4) 0.42 
Other 
Symptoms 
Baseline 49.9 ± 17.8 52.8 ± 19.9   
6-month 69.6 ± 16.5 65.7 ± 20.5   
Change Score a 18.0 ± 20.5 15.4 ± 20.4 -2.6 (-8.3, 3.1) 0.37 
ADL Baseline 60.9 ± 21.0 61.8 ± 19.8   
6-month 77.8 ± 18.0 74.2 ± 17.5   
Change Score a 17.7 ± 22.5 12.6 ± 20.3 -5.0 (-11.1, 1.0) 0.10 
Sport and 
Recreation 
Baseline 29.1 ± 22.8 28.0 ± 22.3   
6-month 46.5 ± 24.1 43.1 ± 24.2   
Change Score a 17.6 ± 28.5 14.5 ± 26.1 -3.1 (-10.8, 4.5) 0.42 
Quality of life Baseline 30.2 ± 19.8 25.0 ± 30.1   
6-month 49.0 ± 22.0 43.1 ± 24.2    
Change Score a 18.4 ± 23.5 16.4 ± 22.2 -2.0 (-8.4, 4.4) 0.55 
KOOS Total Baseline 50.9 ± 18.8 50.3 ± 17.2   
6-month 68.3 ± 16.9 64.7 ± 17.1   
Change Score a 17.9 ± 20.4 14.4 ± 19.1 -3.5 (-9.1, 2.0) 0.21 
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Figure 8: Mean time to return to full weight-bearing with complete discontinuation 
of gait aid use (in weeks with 95% confidence intervals) for patients undergoing a 
medial opening wedge high tibial osteotomy with a locking or non-locking internal 
fixation plate. Stars indicate a significant difference. 
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Figure 9: Mean Knee injury and Osteoarthritis Outcome Score (KOOS) total and 
subdomain change scores from baseline to six months postoperative (with 95% 
confidence intervals) for patients undergoing a medial opening wedge high tibial 
osteotomy with a locking or non-locking internal fixation plate. 
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3.5.3 Objective 3 
There was a statistically significant difference between groups in mean costs from the 
healthcare payer perspective favoring the non-locking plate group (Table 5). A 
statistically significant difference was also seen from the societal perspective, however 
favoring the locking plate group. The mean between group difference in effect (KOOS 
change score) was small and not statistically significant, but favored the locking plate 
group. Missing 12-month data values were imputed for 19 patients in the locking plate 
group (13.2%) and 12 patients in the non-locking plate group (11.4%). 
 
3.5.3.1 ICER  
The ICER was $472.00 per one point improvement in the total KOOS change score for 
the healthcare payer perspective (Table 5), translating to an additional $4,720 per patient 
for a clinically important improvement of ten KOOS points compared to patients who 
receive a non-locking plate. The ICER was -$3892.63 for the societal perspective, 
indicating a cost saving of $3892.63 per additional one point improvement in total KOOS 
change score in favor of the locking plate group. The negative incremental cost and 
positive incremental effect from the ICER suggest that, when incorporating indirect costs, 
the locking plate costs less for a better outcome compared to the non-locking plate. 
 
3.5.3.2 Net Benefit Regression 
From the healthcare payer perspective, the incremental net benefit (INB) was negative for 
WTP values <$1,000, indicating that the locking plate is not cost-effective compared to 
the non-locking plate below this WTP threshold (Table 6). At a WTP ≥ $1,000, the 
positive INB indicates that the locking plate is cost-effective compared to the non-locking 
plate at this threshold. From a societal perspective, the INB was positive for all WTP 
suggesting that the locking plate is cost-effective compared to the non-locking plate. 
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3.5.3.2.1 Uncertainty 
From the healthcare payer perspective, the 95% confidence intervals (CI) around our 
estimate widen as WTP increases and at WTP values ≥$1,000, the lower bounds of the 
95% CIs remain negative. The larger confidence intervals suggest a higher degree of 
uncertainty surrounding the cost-effectiveness of the locking plate as one is willing to pay 
more. From the societal perspective, the lower bounds of the CI remain positive up to a 
WTP of $500, however become negative at values >$500 and these CIs continue to 
widen as WTP increases also suggesting uncertainty. 
To visually display this uncertainty, the probability of cost-effectiveness for the locking 
plate is displayed on the cost-effectiveness acceptability curve (CEAC) (Figure 10). From 
the healthcare payer perspective, the CEAC suggests that even at a WTP of $1,000 for a 
one point improvement in total KOOS change score (i.e. $10,000 for a clinically 
meaningful improvement), the probability that the locking plate is cost-effective is 50% 
(Figure 10A). From a societal perspective, the CEAC suggests with 99% certainty that 
the locking plate is cost-effective at a WTP value of $0 (Figure 10B). As WTP increases 
however, this certainty slowly declines as a result of cost savings with minimal 
improvement in effect (Fenwick, 2004). 
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Figure 10: Cost-effectiveness acceptability curves (CEAC) displaying the probability 
that the locking plate is cost-effective compared to the non-locking plate from A) the 
healthcare payer’s perspective and B) the societal perspective, over a range of 
willingness to pay values for an additional one-point improvement in the Knee 
injury and Osteoarthritis Outcome Score total change score  (baseline to 12 
months). 
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3.5.3.3 Sensitivity Analysis 
Results from our sensitivity analysis suggest that, from the societal perspective, 
cost savings are 1) $3309.91, 2) $3747.08 and 3) $3595.41 per one point improvement of 
KOOS total change score after adjusting for 1) the dollar value for retired or home 
making time at 0$ per hour, 2) time to return to work = time to return to weight bearing 
plus seven weeks, and 3) both 1) and 2) (Table 7).  
Similarly, the sensitivity analysis provided comparable results when conducting 
net benefit regression. In each of the three sensitivity conditions, the INB was positive for 
all WTP values indicating that the locking plate is cost-effective compared to non-locking 
plate (Table 8). As WTP increases however, the 95% CIs around our estimate widen 
suggesting uncertainty in the cost-effectiveness of the locking plate as one is willing to 
pay more. Visual display of CEACs indicates that at a WTP of $0, there is between 97% 
(Figure 11A) and 99% (Figures 11B and 11C) certainty that the locking plate is cost-
effective compared to the non-locking plate with a slow decline in certainty as the WTP 
increases. 
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Table 5: Sensitivity analyses cost and effect outcomes*. 
*Values are reported as means 
a 2016 Canadian dollars. 
b Total change Knee injury and Osteoarthritis Outcome Score (KOOS) between baseline and 12 months 
† p < 0.05, ‡ p ≤ 0.001 
Abbreviations: ICER = Incremental cost-effectiveness ratio, CI = confidence interval 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Societal Sensitivity Analysis 1 (n = 164, CL = 106, PUD = 58) 
Plate Cost*,a Δ Cost CI, p-value Effect*,b Δ Effect CI, p-value ICER 
Locking 23679.56 -5295.86 (-9873.7, -716.5) , 
0.02† 
21.32 +1.60 (-6.1, 2.9), 
0.49 
-3309.91 
Non-locking 28975.42  19.72   
Societal Sensitivity Analysis 2 (n = 249, CL = 144, PUD = 105) 
Plate Cost*,a Δ Cost CI, p-value Effect*,b Δ Effect CI, p-value ICER 
Locking 24214.74 -5995.32 (-8897.5, -3093.1), 
<0.01‡ 
21.32 +1.60 (-6.1, 2.9), 
0.49 
-3747.08 
Non-locking 30210.06  19.72   
Societal Sensitivity Analysis 3 (n = 249, CL = 144, PUD = 105) 
Plate Cost*,a Δ Cost CI, p-value Effect*,b Δ Effect CI, p-value ICER 
Locking 24056.14 -5752.66 (-8760.0, -2745.3), 
<0.01‡  
21.32 +1.60 (-6.1, 2.9), 
0.49 
-3595.41 
Non-locking 29808.81  19.72   
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Table 6: Sensitivity analyses net benefit regression results. 
* WTP for a one-point improvement on the KOOS total change score from baseline to 12 months 
** Incremental net benefit with standard error (SE) 
a A positive incremental net benefit favors the locking plate treatment group 
† p < 0.05, ‡ p ≤ 0.001 
Abbreviations: WTP = willingness-to-pay, CI = confidence interval 
 
 
 Societal Sensitivity Analysis 1 (n = 164, CL = 106, PUD = 58) 
WTP* Incremental net benefit 95% CI p-value 
0 4238.26 (2240.09) -186.6 to 8663.1 0.060 
250 4609.59 (2419.84) -170.3 to 9389.5 0.059 
500 4980.91 (2832.09) -613.3 to 10575.1 0.081 
750 5352.24 (3393.11) -1350.1 to 12054.6 0.117 
1000 5723.56 (4041.43) -2259.4 to 13706.5 0.159 
1250 6094.89 (4741.36) -3270.7 to 15460.4 0.201 
1500 6466.22 (5473.14) -4344.8 to 17277.2 0.239 
1750 6837.54 (6225.55) -5459.7 to 19134.8 0.274 
2000 7208.87 (6991.93) -6602.2 to 21019.9 0.304 
 Societal Sensitivity Analysis 2 (n = 249, CL = 144, PUD = 105) 
WTP* Incremental net benefit 95% CI p-value 
0 5446.01 (1480.25) 2529.9 to 8362.3 <0.001‡ 
250 5653.11 (1621.99) 2457.8 to 8848.5 0.001‡ 
500 5860.22 (1949.72) 2019.3 to 9701.2 0.003† 
750 6067.32 (2388.05) 1362.8 to 10771.8 0.012† 
1000 6274.43 (2887.03) 586.9 to 11961.9 0.031† 
1250 6481.53 (3420.22) -256.4 to 13219.5 0.059 
1500 6688.64 (3973.88) -1140.0 to 14517.3 0.094 
1750 6895.75 (4540.52) -2049.2 to 15840.7 0.130 
2000 7102.85 (5115.84) -2975.5 to 17181.2 0.166 
 Societal Sensitivity Analysis 3 (n = 249, CL = 144, PUD = 105) 
WTP* Incremental net benefit 95% CI p-value 
0 5087.07 (1539.42) 2054.4 to 8119.8 0.001‡ 
250 5294.18 (1672.44) 1999.4 to 8588.9 0.002† 
500 5501.28 (1988.74) 1583.4 to 9419.1 0.006† 
750 5708.39 (2417.42) 946.0 to 10470.8 0.019† 
1000 5915.50 (2909.23) 184.3 to 11646.7 0.043† 
1250 6122.60 (3437.16) -648.7 to 12893.9 0.076 
1500 6329.71 (3986.90) -1524.6 to 14184.0 0.114 
1750 6536.81 (4550.55) -2427.8 to 15501.5 0.152 
2000 6743.92 (5123.52) -3349.5 to 16837.4 0.189 
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Figure 11: Sensitivity analysis cost-effectiveness acceptability curves (CEAC) 
displaying the probability that the locking plate is cost-effective compared to the 
non-locking plate from the societal perspective over a range of willingness to pay 
values for an additional one-point improvement in the Knee injury and 
Osteoarthritis Outcome Score total change score (baseline to 12 months). A) 
Adjusting the dollar value for retirement or home making time, B) Adjusting the 
time to return to work, C) Combining the two previous adjustments. 
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Chapter 4  
4 Discussion 
The present study is the first to investigate the clinical and cost-effectiveness of a locking 
plate compared to a non-locking plate in patients undergoing medial opening wedge 
HTO. We found statistically significant differences in time to return to full weight-
bearing favoring the locking plate group, while there were no statistically significant 
differences in the KOOS total change score or any of its subdomains from baseline to six 
months between the two plate groups. Our results also suggest that the locking plate is 
unlikely to be cost-effective from the healthcare payer perspective, although it may be 
cost-effective from the societal perspective. 
With the suggested additional stability that the locking plate provides, we expected these 
patients to return to full weight-bearing much faster than patients who received the non-
locking plate. In line with our hypothesis, we found that patients who underwent HTO 
with the locking plate returned to full weight-bearing without gait aid use at a mean 10.9 
± 5.8 weeks after surgery, which was significantly sooner than patients receiving the 
locking plate whose return to full weight-bearing time was 17 ± 6.5 weeks (between 
group difference = 6.1 weeks, 95% CI 4.5, 7.6). The present findings are in line with 
those from Asik et al. who report return to full weight-bearing times of approximately 
three months after surgery among 65 patients who received a non-locking plate24.  
Reports in the literature for time to return to full weight-bearing in locking plates vary 
considerably. Lobenhoffer and Agneskirchner reported that patients who received a 
locking plate (Synthes TomoFix Plate®) began full weight-bearing as early as six to nine 
weeks postoperative, however it is unclear whether this was with complete 
discontinuation of crutch use or if the patient was able to put full weight on the operative 
limb with assisted crutch use177. Staubli et al. reported that patients returned to full 
weight-bearing without crutches at ten weeks after surgery on average when using a 
locking plate (Synthes TomoFix Plate®)178, while Brosset et al. reported a mean 3 
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months to return to full weight-bearing without gait aid assistance among 51 patients 
using the same locking plate39.  
Hernigou et al. also compared patients receiving locking and non-locking HTO plates 
(Limmed Plate®). They found that 80% of patients began full weight-bearing on the 
operative limb without crutches at a mere two weeks following the HTO when locking 
screws were used (n = 85), while matched control patients who received non-locking 
screws (n = 85) took three months to return to full weight-bearing. However, their patient 
sample is considered a healthy weight (BMI between 20 and 25 kg/m2)37, whereas our 
patient sample is considered borderline obese (BMI ≈ 30 kg/m2). It is therefore difficult 
to compare our results with the results from Hernigou et al. as previous studies have 
emphasized the importance of handling the rehabilitation process after HTO in obese 
patients with care due to a longer period time required for healing129,179,180.  
A recent study from Landsdaal et al. investigated the functional impacts of early weight-
bearing for patients undergoing medial opening wedge HTO with a locking HTO plate 
(Synthes TomoFix Plate®) in a randomized control trial30. They found that although 
patients were able to immediately begin weight-bearing (45 days earlier than their 
delayed weight-bearing group), 29% of patients in the immediate weight-bearing group 
(n = 25) were still using crutches at three months compared to only 17% of the delayed 
weight-bearing group patients (n = 25). This suggests that goals should perhaps not be 
aimed at allowing patients to immediately begin weight-bearing after HTO surgery, but 
instead identifying the optimal time period to begin the weight-bearing process that 
promotes bone healing in a safe manner. 
A primary concern for surgeons in allowing patients an early return to full weight-bearing 
without crutches is the risk of post-operative complications. However, we found that 
despite a much faster return to full weight-bearing for the locking plate patients, post-
operative complications were generally similar between the two groups aside from 
hardware failures which occurred slightly more frequently in patients receiving the non-
locking plate. This is likely because of the lack of primary stability that the non-locking 
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plate provides with excess motion to the osteotomy site and increased stress on the plate 
and screws33,35. Although we expected to see higher rates of plate removal in the locking 
plate group, the number of cases between groups is similar. It is important to note 
however, that plate removals were only reported up to 12 months following the HTO to 
be included in our cost-effectiveness analysis. 
Based on the suggested quicker return to full weight-bearing with the locking plate, we 
expected to see earlier improvements in patient-reported outcomes in these patients when 
compared to those receiving the non-locking plate. Although the KOOS total and 
subdomain change scores are slightly higher in the locking plate group from baseline to 
six months after surgery, the between-group differences are not statistically significant. 
No other studies have compared KOOS scores between the locking plate and non-locking 
plate, however the large improvements in KOOS seen for both treatment groups from 
baseline to six months after the surgery is similar to results found in the literature. 
Brinkman et al. found significant improvements for early weight-bearing patients when 
using a locking plate (Synthes TomoFix Plate®, n = 14), with a change score ranging 
between 8 and 35 points from baseline to six months in individual KOOS subdomains27. 
Birmingham et al. also found significant improvements in all KOOS domains from 
baseline to six months when using a non-locking plate (Arthrex Puddu Plate®, n = 126), 
although the six month KOOS score mean values were not reported (primary outcomes 
were 24-month data)122.  
Results from our CEA suggest that the use of a locking plate for fixation in medial 
opening wedge HTO is unlikely to be cost-effective from the healthcare payer 
perspective, although it may be cost-effective from the societal perspective. In terms of 
effectiveness, we found statistical uncertainty surrounding the small difference in 
improvement seen in the KOOS total change score that favors the locking plate group 
(+1.60 KOOS total change point; 95% CI -6.1, 2.9) indicating that either intervention 
could be the favorable treatment. Therefore, our results are driven heavily by differences 
in costs between the two interventions.  
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In our sample, we found that the initial surgical costs are very similar between groups 
with similar rates of postoperative complications requiring additional intervention (i.e. 
revision surgery, etc.). The difference in overall cost between the two interventions 
(+$755.20 for the locking plate) is reflected in the raw plate and screw costs ($1,192.43 
for the non-locking plate (Arthrex Puddu Plate®) and $1,827.43 for the locking plate 
(Arthrex ContourLock HTO Plate®)). The ICER value of +$472.00 per one additional 
point improvement in the KOOS total change score suggests that the Ministry of Health 
must be willing to pay almost $5,000 more per patient to achieve a clinically important 
improvement in KOOS score, however due to the similar outcomes between groups, it is 
unlikely to be cost-effective. This is further supported with the results from the NBR 
(Table 6) and the CEAC (Figure 10A) which show that the probability that the locking 
plate is cost-effective from the payer perspective plateaus at around 55% at a WTP of 
$1,000 (Figure 10A) with probabilities less than half of that when WTP < $1,000, making 
the non-locking plate a more attractive treatment option for institutional decision makers 
in terms of saving healthcare dollars. 
On the other hand, we did find the locking plate to be cost-effective from the societal 
perspective, which incorporates indirect costs such as time off work, retirement and home 
making and out-of-pocket expenses for the patient. The difference in overall societal 
costs between treatment groups favored the locking plate with an estimated $6,228.21 
cost saving at 12 months following the HTO. The cost difference is largely due to a much 
sooner time to return to employment/activities and reduction in productivity losses for 
patients receiving the locking plate. These conclusions are supported from our NBR 
model (Table 6) and CEAC (Figure 10B) which suggest that there is a 99% probability 
that the locking plate is cost-effective at a WTP of $0, however this certainty slowly 
decreases as the WTP value increases (Figure 10B). This is explained by the uncertainty 
surrounding the incremental effect between the two treatment groups. The wide 
confidence intervals around our estimated incremental effect (95% CI -6.1, 2.9) indicate 
that using the locking plate does not always result in health gains and therefore, the 
CEAC is a slowly decreasing function of WTP181. 
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Both perspectives provide valuable information in the process of decision-making. A few 
essential aspects specific to HTO are worth considering when making decisions. The 
rehabilitation period after HTO surgery is deemed fairly lengthy with a period of crutch 
ambulation that can continue several weeks after surgery as evidenced by numerous 
studies in the literature24,30,39,177,178 and results from our study (Table 3). Consequently, 
employed patients are often off work for extended periods of time and retired and home 
making patients are often limited in their everyday activities for many weeks which can 
generate large losses in productivity for society. 
The viewpoint of institutional decision makers is often quite restrictive to direct system 
costs and sometimes fails to consider the overall societal impacts. From our results, the 
decision maker may opt for using the non-locking plate due to significantly lower cost; 
however considering solely the healthcare payer perspective could significantly 
undermine the true benefit the locking plate for society. Ignoring these important costs in 
CEA can lead to inefficient allocation of resources both short and long-term for society as 
a whole182. The societal perspective theoretically includes all costs relating directly to the 
patient, their families, the public, and government expenditures as a whole, making for a 
more comprehensive analysis. Although much attention is given to the direct healthcare 
costs associated with OA in current economic analyses, workforce absenteeism has been 
shown to contribute considerably to the burden of OA in Canada182. One study estimated 
that 80% of the overall annual costs for OA result from time lost from employment and 
leisure by both participants and unpaid caregivers143. Therefore, it is important for 
decision makers to consider the entire scope of incurred costs when allocating resources. 
It is important to consider both perspectives for decision making, however most 
organizations such as The Canadian Agency for Drugs and Technologies in Health 
advocate that the societal perspective holds the most importance for the entire 
population’s best interest160. 
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Our center performs approximately 75 to 100 HTO surgeries annually. In the eyes of the 
healthcare payer, using the non-locking (Arthrex Puddu Plate®) for HTO could save 
$755.20 for every patient (equivalent to approximately $56,500 cost saving annually). 
When examining from a societal perspective, the costs associated with using the locking 
(Arthrex ContourLock HTO Plate®) over the non-locking plate are offset by significant 
savings to society (equivalent to approximately $467,000 cost saving annually). 
Ultimately, it may require surgeons to advocate the use of socioeconomically favorable 
treatment interventions and offer perspective to governing boards who remain restrictive 
in the decision-making process. Potential solutions include the reallocation of funds for 
surgical equipment to offset the higher cost of locking plates and profit from its societal 
cost savings, benefiting from both perspectives. For example, bone graft and substitutes 
cost between $500 and $750 per HTO procedure. Recent evidence suggests that the use 
bone graft or substitutes may be unnecessary when using a stronger locking plates as 
patients experience similar improvements in clinical outcomes without an increase in 
complication rates125. Eliminating the cost of graft could offset the higher cost of the 
locking plate designs; however this is a question that demands further research. 
 
4.1 Strengths & Limitations 
To our knowledge, our study is the first to investigate clinical outcomes for the Arthrex 
ContourLock HTO Plate® and also the first to compare the cost-effectiveness of plate 
design in medial opening wedge HTO. The strengths of this study include the use of 
validated disease/joint specific outcomes and a large sample size. Furthermore, the use of 
the net benefit regression framework in our CEA allowed us to control for baseline 
variables and to explore potential interaction terms for a richer understanding of the cost-
effectiveness, which can be limited when solely exploring incremental cost-effectiveness 
ratios173.  
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Perhaps the biggest limitation in our study was the retrospective design. The decision to 
use a locking vs. non-locking plate resulted from a shift in clinical practice. The lack of 
group randomization makes our study susceptible to biases that could factor into patient 
improvement after surgery as a result of between-group differences in baseline 
characteristics. However, baseline demographic and clinical characteristics that were 
believed to influence outcomes in this study are similar between groups and were also 
controlled for in our cost-effectiveness analysis. 
Slight between-group differences are seen in the degree of joint degeneration in the 
lateral compartment of the knee (more severe for the locking plate group). There are also 
between-group differences in the number of concomitant tibial tubercle osteotomy 
surgeries performed (more in the locking group), the number of outpatient procedures 
(more in the locking group) and the number of osteotomies that were left unfilled, with 
no bone graft (more in the non-locking group). For these characteristics, time was likely a 
factor contributing to between-group differences as a result of the shift in clinical 
practice. Differences in lateral compartment degeneration could have resulted from 
differences in measurement between radiographic assessors or surgeon expertise over 
time treating more advance OA cases. Differences in the number of TTOs, outpatient 
procedures performed and osteotomy gaps left unfilled could have resulted from changes 
in medical practice over time. However, these clinical and surgical characteristics are not 
thought to have influenced the outcomes investigated in this study. 
Another large limitation in our study is the high volume of assumptions that were made 
when assessing patient charts such as identifying the exact time to return to full weight-
bearing without crutches. Although data extraction methods were standardized for the 
two treatment groups, data collected prospectively (i.e. through questionnaires) may have 
been more precise. Prospective data collection would have also allowed us to address 
other relevant questions such as patient satisfaction following the surgery (i.e. related to 
return to weight-bearing rehabilitation process). 
70 
 
 
 
Further, patients who filled out cost questionnaires in our study were asked to recall how 
long they were off work after surgery, making our data susceptible to recall bias. To 
minimize this, response options were presented in 2-month increments (i.e. 3-4 months). 
Another limitation to our study is that all surgeries were performed by a single surgeon. 
This presents the risk for expertise bias that could influence interpretation of bone 
consolidation and pain in deciding whether to allow the patient to begin full weight-
bearing. Additionally, complication rates from our study are low when compared to 
previous studies24,126,134–139. The surgeon’s expertise could have resulted in the lower 
complication rate from years of experience performing HTO procedures, which threatens 
the external validity (generalizability) of the results to other clinical practices. 
Specifically, the frequency of hardware removals reported for patients receiving a locking 
plate are quite low when compared to previous studies who report over 80% removal 
rate29,40. Although we were unable to control for this in our cost-effectiveness analysis 
that uses trial-based data, alternative model-based analyses can use complication and 
plate removal rates reported in the literature to generate cost estimates. 
The generalizability of this study is also threatened by the fact that all surgeries were 
performed at a single center. For example, our center receives a pro-rate on charges for 
some surgical equipment costs due to the high volume of HTO cases performed annually, 
which may not translate to costing at other centers. It is important also to note that this 
study was designed to evaluate the clinical and cost-effectiveness of using the Arthrex 
ContourLock HTO Plate® (locking) over the Arthrex Puddu Plate® (non-locking) for 
medial opening wedge HTO in patients with medial compartment knee OA and varus 
alignment and therefore conclusions should not be drawn for patients receiving variations 
of the osteotomy procedure (i.e. lateral closing wedge HTO, distal femoral osteotomy, 
etc.), who are valgus aligned or undergo HTO using a different internal fixation plate. 
Another potential limitation for this study is the 12-month follow-up period. Previous 
studies have indicated that the survivorship of a HTO can exceed 15 years130 and the 
optimal economic analysis would incorporate all lifetime costing159 which includes 
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revision and co-interventions past the 12 month mark (i.e. revision HTO, conversion to 
TKA or UKA, etc.). However, the likelihood that large differences in cost exist between a 
locking plate and non-locking plate past the 12 month mark is low since the majority of 
post-operative complications occur within the first 12 months of surgery, as does the 
progression to full weight-bearing28,30,36,126,179. 
Finally, some costs typically included in CEAs to capture a more comprehensive societal 
perspective were omitted due to the retrospective nature of the study. Direct costs related 
to out-of-pocket expenses for the patient/caregivers and over-the-counter 
medication/aids, as well as indirect costs related to time lost from the caregiver were not 
available to be included in the study. Therefore, our total cost values are likely 
underestimated. However, we suspect that addition of these costs would increase the cost 
difference between groups as a result of a much quicker return to full weight-bearing for 
the locking plate group. Our estimate is therefore conservative. 
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Chapter 5  
5 Conclusion 
We found that patients who received a locking plate (Arthrex ContourLock HTO Plate®) 
for medial opening wedge HTO returned to full weight-bearing without assistance of gait 
aid significantly faster than patients who received a non-locking plate (Arthrex Puddu 
Plate®). No significant between-group differences were found for the change in KOOS 
from baseline to six months after surgery. Results from our CEA indicate that the locking 
plate is not cost-effective from the healthcare payer’s perspective as a result of higher 
initial plate and screw costs. The locking plate is however, cost-effective from the 
societal perspective as patients return to work much faster after the surgery. 
 
5.1 Future Directions 
The retrospective nature of this study required a high volume of assumptions to be made 
during data extraction, opening the opportunity for improved study design in future 
investigations. Prospective studies should aim to introduce more surgeons and 
orthopaedic centers to make results from this study (i.e. complication rates, cost, etc.) 
more generalizable to all medial opening wedge HTO procedures while including various 
different locking and non-locking plate designs. Time to return to weight-bearing and 
time to return to work should be collected prospectively, along with direct patient costs, 
caregiver costs and other out-of-pocket expenses that would generate a more complete 
CEA estimate.  
Results from this study indicate that the locking plate allows patients to return to full 
weight-bearing much quicker after HTO. It would therefore be important to evaluate 
patient outcomes (i.e. change in muscle strength, functional outcomes, etc.) at shorter 
follow-up times (i.e. 3 months) to observe if the differences in return to full weight-
bearing time could also affect the rate of improvement in patient activities of daily living, 
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quality of life and gait mechanics. Finally, studies should be conducted to determine 
whether costs can be minimized when eliminating bone graft or substitute in HTO 
procedures when a locking plate is used, as some studies have suggested that bone graft is 
not necessary for these cases125. In turn, we could benefit from both the healthcare and 
societal viewpoints of cost when using a locking plate. 
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